Science
Today, one of the big debates in medicine revolves around how much we’re willing to pay for cures. In this latest episode of the Signal podcast, we focus in on hepatitis C, a chronic viral infection of the liver that affects at least 130 million people worldwide. New drugs that cure hep C emerged in recent years, but they're pricey — as much as $94,500 for a course of treatment. Too high? What's a reasonable price to pay to cure one person? And what if there were millions to cure at that price? The Signal podcast is produced by Katie Hiler. Illustration by Molly Ferguson for STAT.